Molnupiravir - activities

Coronavirus: the Haute Autorité de Santé does not approve emergency marketing of molnupiravir

The Haute Autorité de Santé announced - in a report issued on December 10 - they do not approve the emergency use of molnupiravir (Lafevrio) to prevent coronavirus infection. The issue goes against what the European Medicines Agency announced this past November 19, namely approving the emergency use of the drug in case of emergency.

Covid: why is looking for a therapy more difficult than for a vaccine?

As several Covid vaccines are being given in the whole world, over 1.5 year of pandemic, the search for therapies is still groping around. Why is looking for a coronavirus therapy more difficult? Food for thoughts…